DRREDDY
Dr. Reddy's Laboratories
Pharma · quarter ended 2024-12-31
- Revenue
- ₹8,381 Cr
- Expenses
- ₹6,661 Cr
- Operating profit
- ₹1,720 Cr
- Op. margin
- 20.5%
- Net profit
- ₹1,404 Cr
Where the revenue comes from
| Segment | Revenue | Share | Segment result | Segment margin |
|---|---|---|---|---|
| Global Generics | ₹7,381 Cr | 86.0% | ₹4,522 Cr | 61.3% |
| Pharmaceutical Services and Active Ingredients | ₹1,039 Cr | 12.1% | ₹236 Cr | 22.7% |
| Others | ₹161 Cr | 1.9% | ₹148 Cr | 91.6% |